{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:59:31Z","timestamp":1793059171498,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":688,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008367","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","award":["5C06G000010"],"award-info":[{"award-number":["5C06G000010"]}],"id":[{"id":"10.13039\/501100008367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["APQ-00325-20"],"award-info":[{"award-number":["APQ-00325-20"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1186\/s13613-024-01369-0","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T13:02:12Z","timestamp":1725454932000},"page":"139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Angiotensin-(1\u20137) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1\u20132 randomized clinical trial"],"prefix":"10.1016","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct04633772","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ana Luiza Valle","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Annoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe Alex","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Bolais-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Capanema","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Cunha","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella Monique Lana","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuanny Granato Fonseca","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Dias","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Abdo","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana Helen","family":"dos Santos Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Motta-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Campagnole-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Verano-Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Silvio","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson Augusto Souza","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/s13613-024-01369-0_bb0010","unstructured":"https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c- Assessed 22 Jan 2024."},{"issue":"11","key":"10.1186\/s13613-024-01369-0_bb0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1186\/s13613-024-01369-0_bb0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1186\/s13613-024-01369-0_bb0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1186\/s13613-024-01369-0_bb0030","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of Coronavirus disease 2019 in China For the China Medical Treatment Expert Group for Covid-19","volume":"382","author":"Wei-Jie","year":"2020","journal-title":"N Eng J Med"},{"issue":"8","key":"10.1186\/s13613-024-01369-0_bb0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19\u2014preliminary report","volume":"384","author":"RECOVERY Collaborative Group","year":"2020","journal-title":"New Eng J Med"},{"key":"10.1186\/s13613-024-01369-0_bb0040","unstructured":"Therapeutics and COVID-19. Geneva: World Health Organization; 2022 (https:\/\/www.who.int\/teams\/health-care-readiness\/covid-19\/therapeutics. Accessed 15 Dec 2023."},{"issue":"19","key":"10.1186\/s13613-024-01369-0_bb0045","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014final report","volume":"383","author":"ACTT-1 Study Group Members","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-024-01369-0_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffman","year":"2020","journal-title":"Cell"},{"key":"10.1186\/s13613-024-01369-0_bb0055","author":"Santos","year":"2019"},{"issue":"1","key":"10.1186\/s13613-024-01369-0_bb0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1\u20137)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1\u20137)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1186\/s13613-024-01369-0_bb0065","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1186\/s13613-024-01369-0_bb0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/1381612033455431","article-title":"The pulmonary renin\u2013angiotensin system","volume":"9","author":"Marshall","year":"2003","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1186\/s13613-024-01369-0_bb0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1\u20137) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Sim\u00f5es e Silva","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"7047","key":"10.1186\/s13613-024-01369-0_bb0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1186\/s13613-024-01369-0_bb0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00109-012-0859-2","article-title":"Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury","volume":"90","author":"Rey-Parra","year":"2012","journal-title":"J Mol Me (Berl)"},{"key":"10.1186\/s13613-024-01369-0_bb0090","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1590\/S1807-59322011000500021","article-title":"An orally active formulation of angiotensin-(1\u20137) produces an antithrombotic effect","volume":"66","author":"Fraga-Silva","year":"2011","journal-title":"Clinics"},{"key":"10.1186\/s13613-024-01369-0_bb0095","first-page":"441","article-title":"Angiotensin-(1\u20137) attenuates disuse skeletal muscle atrophy in mice via its receptor","volume":"9","author":"Morales","year":"2016","journal-title":"Mas Dis Model Mech"},{"issue":"4","key":"10.1186\/s13613-024-01369-0_bb0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1\u20137) or an angiotensin II receptor antagonist","volume":"225","author":"W\u00f6sten-van Asperen","year":"2011","journal-title":"J Pathol"},{"issue":"1","key":"10.1186\/s13613-024-01369-0_bb0105","first-page":"44","article-title":"Angiotensin-(1\u20137) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental acute respiratory distress syndrome","volume":"3","author":"Zambelli","year":"2015","journal-title":"Inten Care Med Exp"},{"issue":"4","key":"10.1186\/s13613-024-01369-0_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00592-011-0348-z","article-title":"Angiotensin-(1\u20137) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes","volume":"49","author":"Liu","year":"2012","journal-title":"Acta Diabetol"},{"key":"10.1186\/s13613-024-01369-0_bb0115","doi-asserted-by":"crossref","first-page":"00848","DOI":"10.1183\/23120541.00848-2020","article-title":"Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients","volume":"7","author":"Van Lier","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1186\/s13613-024-01369-0_bb0120","first-page":"00114","article-title":"Increased circulating levels of angiotensin-(1\u20137) in severely ill COVID-19 patients","volume":"7","author":"Martins","year":"2021","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1186\/s13613-024-01369-0_bb0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients with COVID-19: a randomized clinical trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"10.1186\/s13613-024-01369-0_bb0130","article-title":"Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, muticentre, phase 3, randomised controlled trial","volume":"379","author":"Jardine","year":"2022","journal-title":"BMJ"},{"issue":"14","key":"10.1186\/s13613-024-01369-0_bb0135","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.2023.4480","article-title":"Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19","volume":"329","author":"Writing committee for the REMAP-CAP investigators","year":"2023","journal-title":"JAMA"},{"key":"10.1186\/s13613-024-01369-0_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13054-022-04096-9","article-title":"A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1\u20137 (TXA-127) for the treatment of severe COVID-19","volume":"26","author":"Wagener","year":"2022","journal-title":"Crit Care"},{"key":"10.1186\/s13613-024-01369-0_bb0145","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jama.2023.3546","article-title":"Renin-angiotensin system modulation with synthetic angiotensin (1\u20137) and angiotensin II type 1 receptor-biased ligand in adults with COVID-19: two randomized clinical trials","volume":"329","author":"Self","year":"2023","journal-title":"JAMA"},{"key":"10.1186\/s13613-024-01369-0_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-0115(99)00067-1","article-title":"Angiotensin-(1\u20137) binds at the type 1 angiotensin II receptors in rat renal cortex","volume":"84","author":"Gironacci","year":"1999","journal-title":"Regul Pept"},{"key":"10.1186\/s13613-024-01369-0_bb0155","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0024-3205(86)90565-5","article-title":"Biological activities of angiotensin II-(1\u20136)-hexapeptide and angiotensin II-(1\u20137)-heptapeptide in man","volume":"38","author":"Kono","year":"1986","journal-title":"Life Sci"},{"key":"10.1186\/s13613-024-01369-0_bb0160","unstructured":"https:\/\/www.equator-network.org\/reporting-guidelines\/consort. Assessed 8 Jan 2024."},{"key":"10.1186\/s13613-024-01369-0_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s13102-021-00274-4","article-title":"Angiotensin-(1\u20137) oral formulation improves physical performance in mountain bike athletes: a double-blinded crossover study","author":"de Moura","year":"2021","journal-title":"BMC Sports Sci Med Rehabil"},{"issue":"10","key":"10.1186\/s13613-024-01369-0_bb0170","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1055\/a-0633-8892","article-title":"Eccentric overload muscle damage is attenuated by a novel angiotensin- (1\u20137) treatment","volume":"39","author":"Becker","year":"2018","journal-title":"Int J Sports Med"},{"key":"10.1186\/s13613-024-01369-0_bb0175","article-title":"Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2\/3 trial","volume":"68","author":"Lobo","year":"2023","journal-title":"eClinicalMedicine"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-024-01369-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-024-01369-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025002857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025002857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-024-01369-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:48:22Z","timestamp":1776671302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025002857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2110582025002857"],"URL":"https:\/\/doi.org\/10.1186\/s13613-024-01369-0","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-(1\u20137) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1\u20132 randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-024-01369-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 The Author(s) 2024. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"139"}}